Skip to content
ES

Less noise. More signal.

Context · Startups · sweep Tuesday, November 17, 2026

European venture capital rounds in startups and biotech

Three European funds and platforms concentrate growth capital —Pigment, Nevis and Forbion's biotech fund—, a sign that European venture is scaling ticket size while capital shifts toward regulated and infrastructure sectors. It matters because European financing capacity defines the bloc's technological autonomy vis-à-vis the U.S. and China.

Title, thesis and gravity assessment written by an AI model, without prior human review.

Gravity58/100 · Context
Why this gravity
Tres eventos de fundraising: Pigment $250M Series E, Forbion $2.6B (mayor fondo de su historia) y Nevis $70M con EQT Ventures y QuantumLight. Volúmenes relevantes para el venture europeo pero son rondas de capital, no eventos que reordenen la industria ni obliguen acción inmediata del operador.
— Assessment by the Semantic Gravity Engine
Coverage
2 feeds · 2 independent publisher groups (corroborated)
Cross verticals
Startups, Investing, Lifespan & Healthspan
Gravity vs. the previous edition
no change (58)

coverage, not accuracy

First detected Tue, Jul 28 · 113 days trackedGravity evolution
Lead source
Pigment raises $250m Series E led by Scaleup Europe Fund · Sifted (European startups)

More: STAT News

Actors: Scaleup Europe Fund · Pigment · Forbion · EQT Ventures · QuantumLight · Nevis
Timeline · Madrid time
  1. 15:42
  2. 12:27
  3. 17:57
ShareWhatsApp
Related stories